Ho Wan (Howard) Chan is a final-year PhD Candidate in Prof. Shing Fung (Aviva) Chow’s lab at the Department of Pharmacology and Pharmacy, The University of Hong Kong (HKU), and will join Dr. Sally Yunsun Kim’s lab at the Institute of Pharmaceutical Sciences, King’s College London as a Maplethorpe Fellow in October 2025. He obtained his BPharm degree (with First Class Honours) from HKU in 2020 and registered as a pharmacist in Hong Kong in 2021.
Howard’s research interests include developing inhalable nanomedicines to improve therapeutic outcomes for respiratory diseases and non-animal methods for evaluating the efficacy and safety of inhaled drug products. He has published twelve journal articles, including two original research articles in the International Journal of Pharmaceutics and a review article in AAPS PharmSciTech under the special issue "Advances in Drug Delivery by Inhalation - Official Collection from AAPS Inhalation & Nasal Community (INC)" as first author. His accolades received during his PhD studies included a DDL Career Development Grant to develop an in vitro lung cancer organoid efficacy screening platform for inhaled chemotherapeutics, and the prestigious Sir Edward Youde Memorial Fellowship for Research Postgraduate Students (awarded only to three research postgraduate students in Hong Kong annually).
